1 / 4

PharmaPoint: Dry Eye Syndrome - India Drug Forecast and Market Analysis to 2022

Discover the latest insights on Dry Eye Syndrome (DES) in India, including its prevalence, symptoms, diagnosis, and treatment guidelines. Explore the competitive landscape, key drugs, and the projected market growth during the forecast period.

courtneys
Download Presentation

PharmaPoint: Dry Eye Syndrome - India Drug Forecast and Market Analysis to 2022

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PharmaPoint: Dry Eye Syndrome - India Drug Forecast and Market Analysis to 2022 One-Stop Shop for Business Information

  2. Summary Global Data has released its new Country report, “PharmaPoint: Dry Eye Syndrome - India Drug Forecast and Market Analysis to 2022”. Dry eye syndrome (DES), or keratoconjunctivitissicca, is a multifactorial disease of the eye caused by dryness, decreased tear production, or increased tear film evaporation. DES, which is often referred to simply as dry eye, is the most prevalent form of ocular discomfort and irritation. The most common symptoms of DES are ocular irritation and discomfort, foreign body sensation, fatigue, and visual disturbances, which interfere with daily activities. In the elderly population, it is the most common reason for seeking eye care, and this is expected to increase exponentially with an aging demographic. The DES market in India is projected to grow during the forecast period. During the forecast period, the primary market growth driver will be increased awareness of DES and overall improved access to medical care for India’s enormous population.

  3. Scope • Overview of the DES including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape. • Detailed information on the key drugs in India including product description, safety and efficacy profiles as well as a SWOT analysis. • Sales forecast for the top drugs in India from 2012-2022. • Analysis of the impact of key events as well the drivers and restraints affecting India DES market.

  4. Interesting, right? This is just a sneak preview of the full presentation. We hope you like it! To see the rest of it, just click here to view it in full on PowerShow.com. Then, if you’d like, you can also log in to PowerShow.com to download the entire presentation for free.

More Related